(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were higher on Thursday, a day after the Federal Reserve raised interest rates for the first time in almost a decade, signaling confidence in the strength of the world's largest economy. Dow Jones industrial average futures were up 0.39 percent at 17,805, S&P 500 futures were up 0.33 percent at 2,078.75 and Nasdaq 100 futures were up 0.53 percent at 4,687.75.
** KALOBIOS PHARMACEUTICALS INC, Wednesday close $23.59, -53.24 pct premarket
** RETROPHIN INC, Wednesday close $21.35, -6.23 pct premarket
Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested by the FBI on Thursday after a federal investigation involving his former hedge fund and a pharmaceutical company he previously headed. The securities fraud probe of Shkreli, who is now chief executive officer of Turing Pharmaceuticals and KaloBios, stems from his time as manager of hedge fund MSMB Capital Management and CEO of biopharmaceutical company Retrophin, a person familiar with the matter said.
** PANDORA MEDIA INC, Wednesday close $13.44, +19.94 pct premarket
On track for best day since March 2013. A U.S. Copyright Royalty Board raised music royalty rates that Pandora and other Internet radio stations would have to pay.
“We think this new rate was as wise as Solomon in that everyone should walk way with victory,” Albert Fried analysts wrote in a note.
** PIER 1 IMPORTS INC, Wednesday close $5.95, -16.97 pct premarket
The home decor and furniture importer reported lower-than-expected Q3 sales on Wednesday due to weak store traffic; cuts full-year EPS, comparable sales forecasts.
** AVON PRODUCTS INC, Wednesday close $4.09, +20.29 pct premarket
The beauty products maker said it had agreed to sell 80.1 percent of its North America business to private equity firm Cerberus Capital Management LP for $170 million.
** FEDEX CORP, Wednesday close $148.83, +5.83 pct premarket
The package delivery company on Wednesday reported a better-than-expected quarterly net profit, saying higher margins, cost-cutting and a lower effective tax rate offset weak industrial production and global trade.
** GENERAL MILLS INC, Wednesday close $59.19, -2.01 pct premarket
General Mills reported its second straight fall in quarterly sales, hurt by a strong dollar and weak demand for its snacks and baking products in the United States, and the company cut its full-year sales forecast.
** OCULUS INNOVATIVE SCIENCES INC, Wednesday close $1.1, +20.00 pct premarket
The skin and wound-care product maker said the FDA approved its new treatment for burning, itching, erythema, scaling and pain related to dandruff.
** GALAPAGOS NV, Wednesday close $58.9, +6.96 pct premarket
** GILEAD SCIENCES INC, Wednesday close $103.34, +0.75 pct premarket
Belgium’s Galapagos has signed a deal potentially worth more than $2 billion with U.S. firm Gilead to develop a drug targeting inflammatory diseases, reviving a project abandoned by former partner AbbVie.
** MICRON TECHNOLOGY INC, Wednesday close $14.07, +3.41 pct premarket
Morgan Stanley upgraded the memory chipmaker’s stock to “overweight” from “equalweight”, and raised their price target to $18 from $16, saying “Investor anticipation of weak February guidance has driven the stock to new lows, creating a compelling entry point”.
** MOBILEYE NV, Wednesday close $39.84, +3.54 pct premarket
Tesla Motors Inc will continue to use driving assistant software maker's technology in its cars, Fortune magazine reported on Thursday, citing a Tesla spokesman. (for.tn/1mpwaVh)
Mobileye’s stock fell nearly 7 percent on Wednesday after short-selling firm Citron Research tweeted it was the “short of the year: 2016”.
** ACTINIUM PHARMACEUTICALS INC, Wednesday close $1.9, +24.21 pct premarket
The FDA will allow the company to submit an application to market its experimental blood cancer treatment if the drug successfully clears a single late-stage study.
** RITE AID CORP, Wednesday close $7.9, +1.27 pct premarket
The drugstore operator which has agreed to be bought by larger rival Walgreens Boots Alliance Inc WBA.O, reported same-store sales below analysts estimates hurt by the introduction of more low-margin generic drugs.
** GENERAL ELECTRIC CO, Wednesday close $30.98, -0.26 pct premarket
The company predicted on Wednesday a double-digit rise in operating earnings in 2016 to between $1.45 and $1.55 a share and said it would return about $26 billion to shareholders.
** ASTRAZENECA PLC, Wednesday close $33.79, -1.15 pct premarket
The company is to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of blood cancer drug, boosting its long-term growth at the cost of a near-term hit to earnings.
** SHAW COMMUNICATIONS INC, Wednesday close $19.58, -1.69 pct premarket
Canada’s Shaw Communications said on Wednesday it has agreed to buy Wind Mobile, the country’s fourth-largest wireless provider, in a deal that gives it a much-needed presence in the cellular market.
** ORACLE CORP, Wednesday close $38.91, -0.90 pct premarket
The business software maker on Wednesday delivered a third-quarter profit forecast that did not quite meet analysts’ expectations, and the company’s shares fell about 1 percent in extended trading.
** ACCENTURE PLC, Wednesday close $109.08, -1.45 pct premarket
Accenture reported a better-than-expected jump in quarterly revenue, helped by strong growth in its consulting business, particularly in North America.
** AMERICAN INTERNATIONAL GROUP INC, Wednesday close $60.93
AIG said on Wednesday that its board had authorized a $3 billion share repurchase plan.
** HALCON RESOURCES CORP, Wednesday close $0.321
The oil and gas producer on Wednesday announced a one-for-five reverse stock split, effective Jan. 5. (Compiled by Natalie Grover in Bengaluru; Edited by Don Sebastian)